The effect of psychotropic drugs on the occurrence and course of COVID-19

Janusz Rybakowski

doi:10.5114/fpn.2022.117697

Abstract

1/2022 vol. 38

Review article

The effect of psychotropic drugs on the occurrence and course of COVID-19

Janusz Rybakowski ¹

Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland;
Klinika Psychiatrii Dorosłych, Uniwersytet Medyczny w Poznaniu, Poznań, Polska

Farmakoterapia w Psychiatrii i Neurologii 2022, 38 (1), 9–21

DOI: https://doi.org/10.5114/fpn.2022.117697

Online publish date: 2022/08/02

View full text

AMA

Rybakowski J. The effect of psychotropic drugs on the occurrence and course of COVID-19. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2022;38(1):9-21. doi:10.5114/fpn.2022.117697.

APA

Rybakowski, J. (2022). The effect of psychotropic drugs on the occurrence and course of COVID-19. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, 38(1), 9-21. https://doi.org/10.5114/fpn.2022.117697

Chicago

Rybakowski, Janusz. 2022. "The effect of psychotropic drugs on the occurrence and course of COVID-19". Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii 38 (1): 9-21. doi:10.5114/fpn.2022.117697.

Harvard

Rybakowski, J. (2022). The effect of psychotropic drugs on the occurrence and course of COVID-19. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, 38(1), pp.9-21. https://doi.org/10.5114/fpn.2022.117697

MLA

Rybakowski, Janusz. "The effect of psychotropic drugs on the occurrence and course of COVID-19." Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, vol. 38, no. 1, 2022, pp. 9-21. doi:10.5114/fpn.2022.117697.

Vancouver

Rybakowski J. The effect of psychotropic drugs on the occurrence and course of COVID-19. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2022;38(1):9-21. doi:10.5114/fpn.2022.117697.

Keywords

COVID-19, antidepressants, fluvoxamine, antipsychotics, lithium

Abstract

The effect of psychotropic drugs on the occurrence and course of COVID-19

Keywords

Share

Integrated with

Editorial Policies